![Burt Adelman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Burt Adelman
Founder at
Clear Creek Bio, Inc.
Profile
Burt A. Adelman was the founder of Verve Therapeutics, Inc., founded in 2018, where the title held was Chairman from 2018 to 2025.
Dr. Adelman is also the founder of Clear Creek Bio, Inc...
Dr. Adelman currently serves as Director-New England Division at American Cancer Society, Inc. Dr. Adelman also serves as Overseers Director at Tufts University School of Medicine.
Former positions include Chairman at Carrick Therapeutics, Inc. from 2017 to 2018; Director at Progenics Pharmaceuticals, Inc., Achillion Pharmaceuticals, Inc., TetraLogic Pharmaceuticals Corp., New England Healthcare Institute, NeuroHealing Pharmaceuticals, Inc., and Syntimmune, Inc. from 2016 to 2018; Independent Director at Astria Therapeutics, Inc. from 2016 to 2021; Director at Sirona Medical Technologies, Inc. from 2015 to 2021; Executive Vice President-Portfolio Strategy at Biogen MA, Inc. and Biogen, Inc. from 1991 to 2007; Chief Medical Officer, EVP-Research & Development at Dyax Corp.
from 2012 to 2016; Executive Vice President-Development at BioGenetic Technologies, Inc.; Executive Vice President at Biogen Idec New Ventures, Inc. from 1991 to 2008; President-Research & Development at Sesen Bio, Inc. from 2009 to 2011; Senior Advisor at Novo Ventures 1 A; and Associate at The Brigham & Women's Hospital, Inc. Education includes undergraduate studies at Trinity College (Connecticut) and a doctorate from Weill Cornell Medical College conferred in 1976.
Burt Adelman active positions
| Companies | Position | Start |
|---|---|---|
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Corporate Officer/Principal | - |
Clear Creek Bio, Inc.
 Clear Creek Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for nucleotide synthesis | Founder | - |
Tufts University School of Medicine
 Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Former positions of Burt Adelman
| Companies | Position | End |
|---|---|---|
| VERE THER | Founder | 25/07/2025 |
| ASTRIA THERAPEUTICS, INC. | Director/Board Member | 28/01/2021 |
Sirona Medical Technologies, Inc.
 Sirona Medical Technologies, Inc. Medical/Nursing ServicesHealth Services Develops a cardiac mapping and ablation catheter used for the treatment of atrial fibrillation | Director/Board Member | 01/01/2021 |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Engages in developing novel antibody therapies and severe toxicities in bio pharma industry | Director/Board Member | 01/11/2018 |
Carrick Therapeutics Ltd.
 Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for oncological therapy treatment | Chairman | 10/10/2018 |
Training of Burt Adelman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
75
1st degree connections
23
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 23 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
TetraLogic Pharmaceuticals Corp.
 TetraLogic Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases | Health Technology |
Astria Therapeutics, Inc.
 Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Engages in developing novel antibody therapies and severe toxicities in bio pharma industry | Health Technology |
BioGenetic Technologies, Inc.
 BioGenetic Technologies, Inc. Chemicals: AgriculturalProcess Industries Operates as a holding company for the fertilizer manufacturer, Proagro | Process Industries |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
Trinity College (Connecticut)
 Trinity College (Connecticut) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Cancer Society, Inc.
American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Commercial Services |
Biogen Idec New Ventures, Inc.
 Biogen Idec New Ventures, Inc. Investment ManagersFinance Biogen Idec New Ventures' strategy is to select investments in companies developing innovative human therapeutic products or technologies that will drive product discovery and development more efficiently. Their specific areas of interest are companies in Biogen Idec's current therapeutic areas of neurology, oncology and immunology/inflammation, but they also seek opportunities outside these areas that fit their strategies for longer-term growth. The firm invests at all stages of development; most of their investments are in early-stage companies. They also look for investment opportunities where they can leverage their parent's resources and scientific and development expertise to support these investments. | Finance |
New England Healthcare Institute
 New England Healthcare Institute Miscellaneous Commercial ServicesCommercial Services Engages in identifying innovations that improve the quality and lower the costs of health care | Commercial Services |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures invests in companies located in Europe, the United States and Asia. The firm targets companies operating in the fields of health technology, health services, biotechnology and medical specialties sectors. It provides financing for early stage capital requirements. | Finance |
NeuroHealing Pharmaceuticals, Inc.
 NeuroHealing Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug therapies for the post-acute and chronic neuro-rehabilitation patients | Health Technology |
Weill Cornell Medical College
 Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
Tufts University School of Medicine
Tufts University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Carrick Therapeutics Ltd.
Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company for oncological therapy treatment | Health Technology |
Sirona Medical Technologies, Inc.
Sirona Medical Technologies, Inc. Medical/Nursing ServicesHealth Services Develops a cardiac mapping and ablation catheter used for the treatment of atrial fibrillation | Health Services |
Clear Creek Bio, Inc.
Clear Creek Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for nucleotide synthesis | Health Technology |
Verve Therapeutics, Inc.
 Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
- Stock Market
- Insiders
- Burt Adelman
